-
-
-
-
-
-
-
Evolus (EOLS) Misses Q4 EPS by 4c, provides guidance
-
-
-
-
-
-
-
Evolus (EOLS) PT Lowered to $19 at Mizuho
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Evolus (EOLS)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Evolus (EOLS)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS)
-
-
-
-
-
-
-
Evolus (EOLS) Misses Q3 EPS by 18c ; Offers Guidance
-
-
-
-
-
-
-
Evolus (EOLS) Expands Global Footprint with Introduction of Nuceiva in Australia
-
483,110 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


